Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication.

Lucke T, Herrera R, Wacker M, Holle R, Biertz F, Nowak D, Huber RM, Söhler S, Vogelmeier C, Ficker JH, Mückter H, Jörres RA; COSYCONET-Consortium.

PLoS One. 2016 Oct 28;11(10):e0163408. doi: 10.1371/journal.pone.0163408. eCollection 2016.

2.

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.

3.

Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation.

Noteboom B, Jenkins S, Maiorana A, Cecins N, Ng C, Hill K.

J Cardiopulm Rehabil Prev. 2014 Jan-Feb;34(1):75-9. doi: 10.1097/HCR.0000000000000036.

PMID:
24326901
4.
5.

[Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET].

Jörres RA, Welte T, Bals R, Koch A, Schnoor M, Vogelmeier C.

Dtsch Med Wochenschr. 2010 Mar;135(10):446-9. doi: 10.1055/s-0030-1249185. Epub 2010 Mar 2. German.

PMID:
20198540
6.

Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.

Qian J, Simoni-Wastila L, Rattinger GB, Zuckerman IH, Lehmann S, Wei YJ, Stuart B.

Int J Geriatr Psychiatry. 2014 Jan;29(1):49-57. doi: 10.1002/gps.3968. Epub 2013 Apr 19.

7.

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.

Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium.

BMC Pulm Med. 2016 May 10;16(1):70. doi: 10.1186/s12890-016-0238-9.

8.

Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.

López Varela MV, Montes de Oca M, Halbert R, Muiño A, Tálamo C, Pérez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, Menezes AM; PLATINO team.

Arch Bronconeumol. 2013 Nov;49(11):468-74. doi: 10.1016/j.arbres.2013.05.003. Epub 2013 Jul 13. English, Spanish.

9.

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative.

Sediq R, van der Schans J, Dotinga A, Alingh RA, Wilffert B, Bos JH, Schuiling-Veninga CC, Hak E.

Clin Epidemiol. 2018 Aug 16;10:981-989. doi: 10.2147/CLEP.S163037. eCollection 2018.

10.

A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.

Lenferink A, Frith P, van der Valk P, Buckman J, Sladek R, Cafarella P, van der Palen J, Effing T.

Contemp Clin Trials. 2013 Sep;36(1):81-9. doi: 10.1016/j.cct.2013.06.003. Epub 2013 Jun 14.

PMID:
23770110
11.

Multimorbidity and COPD Medication Receipt Among Medicaid Beneficiaries With Newly Diagnosed COPD.

Ajmera M, Sambamoorthi U, Metzger A, Dwibedi N, Rust G, Tworek C.

Respir Care. 2015 Nov;60(11):1592-602. doi: 10.4187/respcare.03788. Epub 2015 Sep 1.

12.

Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention.

Hirsch JD, Metz KR, Hosokawa PW, Libby AM.

Pharmacotherapy. 2014 Aug;34(8):826-35. doi: 10.1002/phar.1452. Epub 2014 Jun 20.

13.

Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study.

Gill JM, Klinkman MS, Chen YX.

J Am Board Fam Med. 2010 Jul-Aug;23(4):499-508. doi: 10.3122/jabfm.2010.04.090299.

14.
15.

History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.

Sadatsafavi M, Tavakoli H, Kendzerska T, Gershon A, To T, Aaron SD, FitzGerald JM; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2016 Feb;13(2):188-96. doi: 10.1513/AnnalsATS.201508-507OC.

PMID:
26599154
16.

Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010.

Ford ES, Mannino DM, Wheaton AG, Presley-Cantrell L, Liu Y, Giles WH, Croft JB.

PLoS One. 2014 Apr 21;9(4):e95305. doi: 10.1371/journal.pone.0095305. eCollection 2014.

17.

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):728-35. doi: 10.1164/rccm.201209-1665OC.

PMID:
23392440
19.

The concordance between self-reported medication use and pharmacy records in pregnant women.

Cheung K, El Marroun H, Elfrink ME, Jaddoe VWV, Visser LE, Stricker BHC.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1119-1125. doi: 10.1002/pds.4264. Epub 2017 Jul 25.

PMID:
28744981
20.

Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population.

Anecchino C, Rossi E, Fanizza C, De Rosa M, Tognoni G, Romero M; working group ARNO project.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):567-74.

Supplemental Content

Support Center